Business Context and Reporting Period
This Form 8-K filing by Profusa, Inc. (PFSA) covers the event date of September 9, 2026. The report addresses the Company's status regarding its listing on The Nasdaq Stock Market LLC.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on regulatory compliance status rather than financial performance metrics.
Material Changes and Events
- Nasdaq Compliance: The Company received a Compliance Determination Letter from Nasdaq confirming compliance with Listing Rule 5550(a)(2) (Bid Price Rule) and Rule 5550(b)(1) (Equity Rule).
- Mandatory Monitoring: Pursuant to Nasdaq Listing Rule 5815(d)(4)(B), the Company is subject to a one-year Mandatory Panel Monitor period.
- Consequences of Future Non-Compliance: If the Company fails to meet the Equity Rule again during the Monitoring Period, it will not be permitted to submit a compliance plan or receive a cure period. Instead, Nasdaq will promptly issue a Staff Delisting Determination.
Outlook, Risks, and Management Commentary
Management intends to continue monitoring compliance with all applicable Nasdaq continued listing requirements. The filing includes standard forward-looking statements cautioning that actual results may differ due to risks related to maintaining listing standards, general economic conditions, and market factors. The Company disclaims any obligation to update these statements unless required by law.
Investor Verification Checklist
- Verify the Company's current stock price and market capitalization to ensure continued adherence to the Bid Price and Equity Rules.
- Review the Company's most recent Form 10-K (for the year ended December 31, 2025) and Form 10-Q filings for detailed financial health and liquidity status.
- Monitor future 8-K filings for any notices of non-compliance during the one-year Mandatory Panel Monitor period.
- Confirm the status of the Press Release dated September 15, 2026, referenced as Exhibit 99.1.